Anti-neutrophil cytoplasmic antibody-associated vasculitis

1 paper

Trial sponsors

Amgen
Company1 trialPhase 132 people
Wang Mo
1 trialPhase 4200 people
Chiba University
1 trialPhase 4140 people
Assistance Publique - Hôpitaux de Paris
1 trialPhase 342 people

Latest

1 in 12 months

Drugs15 Feb

More than Glucose Elimination: Additional Benefits of SGLT2 Inhibitors in Glomerular Diseases

ReviewSGLT2 inhibitors